ArticleNPJ breast cancer2022

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.

Stephanie N Shishido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.